Washington roundup: Biotech execs ask for BioShield reform; security, money at issue April 11, 2006 By Aaron Lorenzo
Veronate Data Crush Inhibitex; Drug's Future Cast Into Doubt April 4, 2006 By Aaron Lorenzo Shares in Inhibitex Inc. plunged by two-thirds Monday after the company released poor Phase III data on Veronate. (BioWorld Today)Read More
Veronate Data Crush Inhibitex; Drug's Future Cast Into Doubt April 4, 2006 By Aaron Lorenzo Shares in Inhibitex Inc. plunged by two-thirds Monday after the company released poor Phase III data on Veronate. (BioWorld Today)Read More